福森药业(01652):余浩铭获委任为独立非执行董事

智通财经
Sep 30

智通财经APP讯,福森药业(01652)发布公告,自2025年9月30日起,施永进先生已辞任独立非执行董事,且不再担任审核委员会主席;余浩铭先生已获委任为独立非执行董事兼审核委员会成员;及李国栋先生已获委任为审核委员会主席。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10